Ilvisinus

Pseudoephedrine Hydrochloride, the active ingredient in Ilvisinus, is a sympathomimetic and ibuprofen is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral combination tablet for systemic use. It relieves nasal congestion, sinus pressure, fever, headache and mild to moderate pain in adults.

GNH USA supplies Ilvisinus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing, regulatory compliance and reliable logistics for global distribution. The company adheres to Good Distribution Practice and provides comprehensive support for product registration and post‑market surveillance.

Ilvisinus combines a decongestant and an NSAID, acting on nasal passages and inflammatory pathways to relieve symptoms. - Nasal congestion: reduces swelling of nasal mucosa to improve airflow. - Sinus pressure: alleviates sinus blockage and associated discomfort. - Headache: provides analgesic relief for tension‑type or sinus‑related headaches. - Fever: lowers elevated body temperature through antipyretic action. - Mild to moderate pain: eases musculoskeletal or dental pain of limited intensity.

Ilvisinus may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry mouth - Nausea - Dizziness - Insomnia - Headache - Gastrointestinal discomfort

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction - Elevated blood pressure or hypertensive crisis - Gastrointestinal bleeding or ulceration - Liver enzyme elevation - Cardiac arrhythmia - Stevens‑Johnson syndrome or other severe skin reactions

Before using Ilvisinus, consider the following precautions to ensure safe and effective use. - Cardiovascular conditions: avoid use in uncontrolled hypertension or severe heart disease. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Renal or hepatic impairment: dose adjustment may be required; monitor function. - Concomitant anticoagulants or antiplatelet agents: increased risk of bleeding. - Store at ambient temperature: keep below 25 °C, protect from moisture and keep in original packaging.

Ilvisinus can interact with other medicines; interactions are classified by their clinical significance.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other sympathomimetics: may cause excessive vasoconstriction. - Anticoagulants (e.g., warfarin): increased bleeding risk due to ibuprofen.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for increased bleeding. - Diuretics: may enhance pseudoephedrine‑induced electrolyte shifts. - Lithium: pseudoephedrine may reduce renal clearance, raising lithium levels.